Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KALEIDO BIOSCIENCES, INC.

(KLDO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about KALEIDO BIOSCIENCES, INC.
12/06Kaleido Biosciences Expands and Extends Collaboration With Janssen
MT
12/06Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potent..
GL
11/15Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ..
GL
11/12Chardan Adjusts Price Target on Kaleido Biosciences to $11 From $15 on Pipeline Assets ..
MT
11/10Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
GL
11/10Kaleido Biosciences, Inc. to Appoint Alison Long as Chief Medical Officer, Effective De..
CI
11/03JMP Securities Adjusts Price Target on Kaleido Biosciences to $22 From $25, Maintains M..
MT
11/01Press Release issued by Kaleido Biosciences, Inc., dated November 1, 2021, furnished he..
PU
11/01Kaleido Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month..
CI
11/01Kaleido Biosciences Reports Third Quarter 2021 Financial Results
AQ
10/20NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
10/19KALEIDO BIOSCIENCES : Morgan Stanley Downgrades Kaleido Biosciences to Underweight from Eq..
MT
10/12KALEIDO BIOSCIENCES : to Participate in the Jefferies Virtual Next Generation IBD Therapeu..
AQ
10/05KALEIDO BIOSCIENCES : Says Bowel Disease Drug Trial Meets Primary Safety Endpoint
MT
10/05KALEIDO BIOSCIENCES : Announces New Clinical and Preclinical Data Supporting Advancement o..
AQ
10/05Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement ..
CI
09/29Kaleido Biosciences to Host Virtual R&D Presentation to Discuss Clinical Data and Pipel..
GL
09/29Kaleido Biosciences, Inc. to Host Virtual R&D Presentation to Discuss Clinical Data and..
CI
09/20KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to S&P Global BMI Index
CI
09/03Kaleido Biosciences, Inc. Receives Warning Letter from the U.S. Food and Drug Administr..
CI
09/02Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Hea..
GL
08/11KALEIDO BIOSCIENCES : Press Release issued by Kaleido Biosciences, Inc., dated August 11, ..
PU
08/11Kaleido Biosciences Reports Second Quarter 2021 Financial Results
GL
08/11Kaleido Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Sec..
CI
08/10KALEIDO BIOSCIENCES : Teams Up With COPD Foundation to Advance KB109 into Phase 2a Clinica..
MT
08/10KALEIDO BIOSCIENCES : and the COPD Foundation Announce a Strategic Collaboration to Advanc..
AQ
08/10Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advan..
CI
08/09KALEIDO BIOSCIENCES : Announces New Chairperson Appointment to its Board of Directors
AQ
08/09Kaleido Biosciences, Inc. Announces Appointment of Theo Melas-Kyriazi as Chairperson of..
CI
08/06KALEIDO BIOSCIENCES : to Participate in the 41st Annual Canaccord Genuity Growth Conferenc..
AQ
07/02KALEIDO BIOSCIENCES : Appoints Jerald Korn Chief Operating Officer
MT
07/02Kaleido Biosciences, Inc. Appoints Jerald Korn as Chief Operating Officer
CI
06/25KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 3000E Value Index
CI
06/25KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell Microcap Value Index
CI
06/25KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell Small Cap Comp Value Index
CI
06/25KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 3000 Value Index
CI
06/25KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 2500 Value Index
CI
06/25KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 2000 Value Index
CI
06/10Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
GL
05/04Certain Stock Options of Kaleido Biosciences, Inc. are subject to a Lock-Up Agreement E..
CI
05/04Certain Restricted Stock Units of Kaleido Biosciences, Inc. are subject to a Lock-Up Ag..
CI
05/04Certain Common Stock of Kaleido Biosciences, Inc. are subject to a Lock-Up Agreement En..
CI
05/04KALEIDO BIOSCIENCES' : Q1 Loss Narrows; Expects Enough Funds to Operate Into Q1 2022
MT
05/04Kaleido Biosciences Reports First Quarter 2021 Financial Results
GL
05/04Kaleido Biosciences, Inc. and Cadena Bio, Inc. Enter into Third Amendment to Loan and S..
CI
05/04Kaleido Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Fir..
CI
04/21KALEIDO BIOSCIENCES : Announces Collaboration with Robert Jenq, M.D., to Explore Potential..
AQ
04/20KALEIDO BIOSCIENCES : to Collaborate with MD Anderson Cancer Center Expert on Microbiome T..
MT
04/20Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
GL
04/20Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
CI
04/15Kaleido Biosciences to Participate in Jefferies Microbiome-Based Therapeutics Summit
GL
03/25KALEIDO BIOSCIENCES : Reports Positive Results from Non-IND Study
AQ
03/24SECTOR UPDATE : Health Care Stocks Climb Premarket Wednesday
MT
03/24KALEIDO BIOSCIENCES : Reports Positive Results From KB109 Study to Treat COVID-19; Shares ..
MT
03/24Kaleido Biosciences Reports Positive Results from Non-IND Study Demonstrating a Reducti..
GL
03/24Kaleido Biosciences, Inc. Reports Positive Results from Non-IND Study Demonstrating a R..
CI
03/09AGILENT TECHNOLOGIES : Brings in Former Kaleido Biosciences Exec as Chief Medical Officer
MT
03/04KALEIDO BIOSCIENCES : Share Dilution Drives Price Target Cut at Chardan
MT
03/04KALEIDO BIOSCIENCES : Chardan Adjusts Price Target on Kaleido Biosciences to $15 From $17...
MT
03/03KALEIDO BIOSCIENCES : Posts Narrower Q4 Loss
MT
03/03Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
GL
03/03Kaleido Biosciences, Inc. Reports Unaudited Consolidated Earnings Results for the Fourt..
CI
03/03Kaleido Biosciences, Inc. Auditor Raises 'Going Concern' Doubt
CI
03/02KALEIDO BIOSCIENCES : to Present at Chardan's 3rd Annual Microbiome Medicines Summit
AQ
03/01Kaleido Biosciences to Present at Chardan's 3rdáAnnual Microbiome Medicines Summit
GL
02/11Kaleido Biosciences Announces the Exercise of the Underwriters' Option to Purchase Addi..
GL
02/09KALEIDO BIOSCIENCES : Piper Sandler Starts Kaleido Biosciences at Overweight With $19 Pric..
MT
02/03Kaleido Biosciences Announces Pricing of Public Offering of Common Stock
GL
02/03Kaleido Biosciences Announces Proposed Public Offering of Common Stock
GL
01/25KALEIDO BIOSCIENCES : Chief Medical Officer Katharine Knobil Steps Down
MT
01/25Kaleido Biosciences, Inc. Announces Resignation of Katharine Knobil as Chief Medical Of..
CI
01/20Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbio..
GL
01/14KALEIDO BIOSCIENCES : Chardan Adjusts Price Target on Kaleido Biosciences to $17.50 From $..
MT
01/14KALEIDO BIOSCIENCES : Chardan Raises Price Target for Kaleido to $17.50 from $10, Citing S..
MT
01/14KALEIDO BIOSCIENCES : Says Study Shows Potential Benefit of KB109 in Mild-to-Moderate COVI..
MT
1  2  3Next
Upcoming event on KALEIDO BIOSCIENCES, INC.
Upcoming sector events